These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3277508)

  • 1. Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.
    Wolfson JS; Hooper DC
    Ann Intern Med; 1988 Feb; 108(2):238-51. PubMed ID: 3277508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE; DeVito JM
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Holmes B; Brogden RN; Richards DM
    Drugs; 1985 Dec; 30(6):482-513. PubMed ID: 3908074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin: clinical pharmacology and clinical use.
    Rowen RC; Michel DJ; Thompson JC
    Pharmacotherapy; 1987; 7(4):92-110. PubMed ID: 3317294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity.
    Goldstein EJ
    Am J Med; 1987 Jun; 82(6B):3-17. PubMed ID: 3111257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin: its potential in clinical practice.
    Lee C; Ronald AR
    Am J Med; 1987 Jun; 82(6B):27-34. PubMed ID: 3300309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone antimicrobial agents.
    Wolfson JS; Hooper DC
    Clin Microbiol Rev; 1989 Oct; 2(4):378-424. PubMed ID: 2680058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin: a quinoline antibiotic.
    Marble DA; Bosso JA
    Drug Intell Clin Pharm; 1986 Apr; 20(4):261-6. PubMed ID: 3516615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxacin: a new fluoroquinolone.
    Jaber LA; Bailey EM; Rybak MJ
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Norfloxacin: a broad-spectrum quinolone for superficial eye infections].
    Grosset J
    Pathol Biol (Paris); 1990 Sep; 38(7):735-41. PubMed ID: 2235090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compassionate use of norfloxacin.
    Heseltine PN; Corrado ML
    Am J Med; 1987 Jun; 82(6B):88-92. PubMed ID: 3605160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolones: their uses in geriatric infections.
    Gantz NM
    Geriatrics; 1988 Jan; 43(1):41-4, 47. PubMed ID: 3335336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
    Sabbaj J; Hoagland VL; Cook T
    Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiclinic study of norfloxacin for treatment of urinary tract infections.
    Schaeffer AJ
    Am J Med; 1987 Jun; 82(6B):53-8. PubMed ID: 3300311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL; Ohm-Smith MJ; Hadley WK
    J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of bacterial resistance in urinary tract infections.
    Goldstein EJ
    Eur Urol; 1991; 19 Suppl 1():28-32. PubMed ID: 2022230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of norfloxacin against bacterial isolates from the urinary tract.
    Qadri SM; Johnson S
    J Natl Med Assoc; 1989 Apr; 81(4):382-5. PubMed ID: 2738947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.